Резюме
Definición
Anamnesis y examen
Principales factores de diagnóstico
- shoulder/hip girdle stiffness
- shoulder/hip girdle pain
- rapid response to corticosteroids
Otros factores de diagnóstico
- acute onset
- low-grade fever
- anorexia
- weight loss
- malaise
- depression
- asthenia
- oligoarticular arthritis
Factores de riesgo
- age ≥50 years
- giant cell arteritis (GCA)
- female sex
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
- CBC
Pruebas diagnósticas que deben considerarse
- TSH
- ultrasound
- MRI
- serum protein electrophoresis
- serum creatine phosphokinase
- rheumatoid factor
- anti-cyclic citrullinated peptide antibodies
Pruebas emergentes
- interleukin (IL)-6
- fluorodeoxyglucose F-18 PET scan
Algoritmo de tratamiento
initial presentation
treatment-resistant or relapse or disease exacerbation
Colaboradores
Autores
Ari Weinreb, MD, PhD
Associate Chief of Rheumatology
VA Greater Los Angeles Healthcare System
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles
CA
Divulgaciones
AW declares that he has no competing interests.
Agradecimientos
Dr Ari Weinreb would like to gratefully acknowledge Dr Lynell Newmarch, a previous contributor to this topic.
Divulgaciones
LN declares that she has no competing interests.
Revisores por pares
Brian F. Mandell, MD, PhD, FACR
Vice Chairman of Medicine for Education
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Editor in Chief
Cleveland Clinic Journal of Medicine
Cleveland Clinic
Cleveland
OH
Divulgaciones
BFM declares that he has no competing interests.
Kuntal Chakravarty, FRCP (London), FRCP (Glasgow), FRCP (Ireland), FACP (USA), FACR (USA)
Consultant Rheumatologist
BHRT University Hospital
Queen’s Hospital
Romford
UK
Divulgaciones
KC declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Nothnagl T, Leeb BF. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica. Drugs Aging. 2006;23:391-402. Resumen
Buttgereit F, Dejaco C, Matteson EL, et al. Polymyalgia rheumatica and giant cell arteritis: A systematic review. JAMA. 2016 Jun 14;315(22):2442-58. Resumen
Dejaco C, Singh YP, Perel P, et al; European League Against Rheumatism; American College of Rheumatology. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67:2569-2580.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Giant cell arteritis (GCA)
- Early rheumatoid arthritis (RA)
- Hypothyroidism
Más DiferencialesGuías de práctica clínica
- 2022 guideline for the prevention and treatment of glucocorticoid induced osteoporosis
- 2022 guideline for vaccinations in patients with rheumatic and musculoskeletal disease
Más Guías de práctica clínicaFolletos para el paciente
Polymyalgia rheumatica
Más Folletos para el pacienteVideos
Venepuncture and phlebotomy: animated demonstration
Más vídeos
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad